Browse studies

Find your next paid study

8 recruiting studies matching your filters

A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Growth Hormone Deficiency (GHD)

The OraGrowtH Phase 3 Trial is a multi-national trial. The goals of the trial are to study LUM-201 as a treatment for Pediatric Growth Hormone Deficiency (PGHD…

Growth Hormone Deficiency (GHD)

Estimated

~$10 – $8,750

Lumos PharmaNCT06948214

Phase 3

CSP #2018 - Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)

The purpose of this study is to determine whether growth hormone replacement therapy (GHRT) is effective versus placebo in the improvement of Quality of Life i…

Adult Growth Hormone DeficiencyMild Traumatic Brain Injury

Estimated

~$10 – $5,625

VA Office of Research and DevelopmentNCT04867317

Phase 2

Growth Hormone Replacement Therapy in Veterans With Gulf War Illness and Adult Growth Hormone Deficiency

The goal of the GWIT Study is to assess whether growth hormone replacement therapy is a safe and effective treatment for veterans with Gulf War Illness (GWI) a…

Gulf War SyndromeAdult Growth Hormone Deficiency

Estimated

~$10 – $6,250

Baylor College of MedicineNCT05355272

The Chromosome 18 Clinical Research Center

Our vision, that of the researchers at the University of Texas Health Science Center at San Antonio, is that every person with a chromosome 18 abnormality will…

Chromosome AberrationsGrowth Hormone DeficiencyHypomyelination

Estimated

~$10 – $750

The University of Texas Health Science Center at San AntonioNCT00227253

A Prospective, Non-interventional (NIS), Long-term, Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

The goal of this study is to further characterise the potential long-term safety risks of lonapegsomatropin in patients treated with lonapegsomatropin under re…

Growth Hormone Deficiency

Estimated

~$10 – $1,050

Ascendis Pharma Endocrinology Division A/SNCT05775523

Phase 4

Effects of Administration of Growth Hormone, Without and With Liraglutide, on AgRP, Energy and Glucose Metabolism in Healthy and GH Deficient Humans

This is a randomized, placebo-controlled, cross-over study with 4 arms. Healthy and GH deficient adults ages 18-45 years will be studied. Arms will consist of …

HealthyGrowth Hormone Deficiency

Estimated

~$10 – $6,250

Columbia UniversityNCT05681299

Phase 2

Interventional Study of Growth Hormone Replacement Therapy in Retired Professional Football Players With Growth Hormone Deficiency

This is a randomized, double-blind, placebo-controlled, parallel-group trial with an open-label extension to evaluate the efficacy of growth hormone (GH) on co…

TBI (Traumatic Brain Injury)Concussion, BrainSport Injury+3 more

Estimated

~$10 – $7,500

Center for Neurological StudiesNCT04121780

A US Multi-center, Prospective, Non-interventional, Long Term, Effectiveness and Safety Study of Patients Treated With SKYTROFA (Lonapegsomatropin)

The goal of this study is to genrate evidence on long-term effectiveness and safety of SKYTROFA (lonapegsomatropin) in patients with growth hormone deficiency …

Growth Hormone Deficiency

Estimated

~$10 – $1,050

Ascendis Pharma Endocrinology Division A/SNCT05820672